Drugs solely approved to treat obesity have minimal to no coverage on most ACA Marketplace plans. Wegovy, a semaglutide approved for weight loss, is included in just 1% of Marketplace plans, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies. Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans. All plans ...
